946 related articles for article (PubMed ID: 15367631)
1. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
[TBL] [Abstract][Full Text] [Related]
2. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.
Fitzgerald KA; McWhirter SM; Faia KL; Rowe DC; Latz E; Golenbock DT; Coyle AJ; Liao SM; Maniatis T
Nat Immunol; 2003 May; 4(5):491-6. PubMed ID: 12692549
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
[TBL] [Abstract][Full Text] [Related]
4. Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophages.
Solis M; Romieu-Mourez R; Goubau D; Grandvaux N; Mesplede T; Julkunen I; Nardin A; Salcedo M; Hiscott J
Eur J Immunol; 2007 Feb; 37(2):528-39. PubMed ID: 17236232
[TBL] [Abstract][Full Text] [Related]
5. SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.
Huang J; Liu T; Xu LG; Chen D; Zhai Z; Shu HB
EMBO J; 2005 Dec; 24(23):4018-28. PubMed ID: 16281057
[TBL] [Abstract][Full Text] [Related]
6. Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon.
Civas A; Génin P; Morin P; Lin R; Hiscott J
J Biol Chem; 2006 Feb; 281(8):4856-66. PubMed ID: 16380379
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.
Han KJ; Su X; Xu LG; Bin LH; Zhang J; Shu HB
J Biol Chem; 2004 Apr; 279(15):15652-61. PubMed ID: 14739303
[TBL] [Abstract][Full Text] [Related]
8. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts.
McWhirter SM; Fitzgerald KA; Rosains J; Rowe DC; Golenbock DT; Maniatis T
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):233-8. PubMed ID: 14679297
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.
Fensterl V; Grotheer D; Berk I; Schlemminger S; Vallbracht A; Dotzauer A
J Virol; 2005 Sep; 79(17):10968-77. PubMed ID: 16103148
[TBL] [Abstract][Full Text] [Related]
10. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection.
Perry AK; Chow EK; Goodnough JB; Yeh WC; Cheng G
J Exp Med; 2004 Jun; 199(12):1651-8. PubMed ID: 15210743
[TBL] [Abstract][Full Text] [Related]
11. Triggering the interferon antiviral response through an IKK-related pathway.
Sharma S; tenOever BR; Grandvaux N; Zhou GP; Lin R; Hiscott J
Science; 2003 May; 300(5622):1148-51. PubMed ID: 12702806
[TBL] [Abstract][Full Text] [Related]
12. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation.
Schröder M; Baran M; Bowie AG
EMBO J; 2008 Aug; 27(15):2147-57. PubMed ID: 18636090
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
Lin R; Yang L; Nakhaei P; Sun Q; Sharif-Askari E; Julkunen I; Hiscott J
J Biol Chem; 2006 Jan; 281(4):2095-103. PubMed ID: 16306043
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses.
Otsuka M; Kato N; Moriyama M; Taniguchi H; Wang Y; Dharel N; Kawabe T; Omata M
Hepatology; 2005 May; 41(5):1004-12. PubMed ID: 15841462
[TBL] [Abstract][Full Text] [Related]
15. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA.
Servant MJ; Grandvaux N; tenOever BR; Duguay D; Lin R; Hiscott J
J Biol Chem; 2003 Mar; 278(11):9441-7. PubMed ID: 12524442
[TBL] [Abstract][Full Text] [Related]
16. SOCS3 Drives Proteasomal Degradation of TBK1 and Negatively Regulates Antiviral Innate Immunity.
Liu D; Sheng C; Gao S; Yao C; Li J; Jiang W; Chen H; Wu J; Pan C; Chen S; Huang W
Mol Cell Biol; 2015 Jul; 35(14):2400-13. PubMed ID: 25939384
[TBL] [Abstract][Full Text] [Related]
17. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
[TBL] [Abstract][Full Text] [Related]
18. Ikkepsilon regulates viral-induced interferon regulatory factor-3 activation via a redox-sensitive pathway.
Indukuri H; Castro SM; Liao SM; Feeney LA; Dorsch M; Coyle AJ; Garofalo RP; Brasier AR; Casola A
Virology; 2006 Sep; 353(1):155-65. PubMed ID: 16806387
[TBL] [Abstract][Full Text] [Related]
19. Roles of an IkappaB kinase-related pathway in human cytomegalovirus-infected vascular smooth muscle cells: a molecular link in pathogen-induced proatherosclerotic conditions.
Gravel SP; Servant MJ
J Biol Chem; 2005 Mar; 280(9):7477-86. PubMed ID: 15619605
[TBL] [Abstract][Full Text] [Related]
20. A20 is a negative regulator of IFN regulatory factor 3 signaling.
Saitoh T; Yamamoto M; Miyagishi M; Taira K; Nakanishi M; Fujita T; Akira S; Yamamoto N; Yamaoka S
J Immunol; 2005 Feb; 174(3):1507-12. PubMed ID: 15661910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
